{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T18:24:55Z","timestamp":1743013495243,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":30,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781071627716"},{"type":"electronic","value":"9781071627723"}],"license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-2772-3_25","type":"book-chapter","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T18:07:03Z","timestamp":1668794823000},"page":"479-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-Throughput Screening to Identify Modulators of Sarcospan"],"prefix":"10.1007","author":[{"given":"Cynthia","family":"Shu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina","family":"Mokhonova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachelle H.","family":"Crosbie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"issue":"1","key":"25_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2044-5040-3-1","volume":"3","author":"JL Marshall","year":"2013","unstructured":"Marshall JL, Crosbie-Watson RH (2013) Sarcospan: a small protein with large potential for Duchenne muscular dystrophy. Skelet Muscle 3(1):1. https:\/\/doi.org\/10.1186\/2044-5040-3-1","journal-title":"Skelet Muscle"},{"issue":"50","key":"25_CR2","doi-asserted-by":"publisher","first-page":"31221","DOI":"10.1074\/jbc.272.50.31221","volume":"272","author":"RH Crosbie","year":"1997","unstructured":"Crosbie RH, Heighway J, Venzke DP, Lee JC, Campbell KP (1997) Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex. J Biol Chem 272(50):31221\u201331224. https:\/\/doi.org\/10.1074\/jbc.272.50.31221","journal-title":"J Biol Chem"},{"issue":"49","key":"25_CR3","doi-asserted-by":"publisher","first-page":"38554","DOI":"10.1074\/jbc.M007799200","volume":"275","author":"R Barresi","year":"2000","unstructured":"Barresi R, Moore SA, Stolle CA, Mendell JR, Campbell KP (2000) Expression of gamma-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem 275(49):38554\u201338560. https:\/\/doi.org\/10.1074\/jbc.M007799200","journal-title":"J Biol Chem"},{"issue":"1","key":"25_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1083\/jcb.145.1.153","volume":"145","author":"RH Crosbie","year":"1999","unstructured":"Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR, Campbell KP (1999) Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145(1):153\u2013165. https:\/\/doi.org\/10.1083\/jcb.145.1.153","journal-title":"J Cell Biol"},{"issue":"13","key":"25_CR5","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1093\/hmg\/9.13.2019","volume":"9","author":"RH Crosbie","year":"2000","unstructured":"Crosbie RH, Lim LE, Moore SA, Hirano M, Hays AP, Maybaum SW, Collin H, Dovico SA, Stolle CA, Fardeau M, Tom\u00e9 FM, Campbell KP (2000) Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum Mol Genet 9(13):2019\u20132027. https:\/\/doi.org\/10.1093\/hmg\/9.13.2019","journal-title":"Hum Mol Genet"},{"issue":"12","key":"25_CR6","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002481","volume":"4","author":"MS Parvatiyar","year":"2015","unstructured":"Parvatiyar MS, Marshall JL, Nguyen RT, Jordan MC, Richardson VA, Roos KP, Crosbie-Watson RH (2015) Sarcospan regulates cardiac isoproterenol response and prevents duchenne muscular dystrophy-associated cardiomyopathy. J Am Heart Assoc 4(12):e002481. https:\/\/doi.org\/10.1161\/JAHA.115.002481","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"25_CR7","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123855","volume":"5","author":"MS Parvatiyar","year":"2019","unstructured":"Parvatiyar MS, Brownstein AJ, Kanashiro-Takeuchi RM, Collado JR, Dieseldorff Jones KM, Gopal J, Hammond KG, Marshall JL, Ferrel A, Beedle AM, Chamberlain JS, Renato Pinto J, Crosbie RH (2019) Stabilization of the cardiac sarcolemma by sarcospan rescues DMD-associated cardiomyopathy. JCI Insight 5(11):e123855. https:\/\/doi.org\/10.1172\/jci.insight.123855","journal-title":"JCI Insight"},{"issue":"24","key":"25_CR8","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1093\/hmg\/ddw356","volume":"25","author":"EM Gibbs","year":"2016","unstructured":"Gibbs EM, Marshall JL, Ma E, Nguyen TM, Hong G, Lam JS, Spencer MJ, Crosbie-Watson RH (2016) High levels of sarcospan are well tolerated and act as a sarcolemmal stabilizer to address skeletal muscle and pulmonary dysfunction in DMD. Hum Mol Genet 25(24):5395\u20135406. https:\/\/doi.org\/10.1093\/hmg\/ddw356","journal-title":"Hum Mol Genet"},{"issue":"12","key":"25_CR9","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1093\/ptj\/85.12.1372","volume":"85","author":"RM Lovering","year":"2005","unstructured":"Lovering RM, Porter NC, Bloch RG (2005) The muscular dystrophies: from genes to therapies. Phys Ther 85(12):1372\u20131388","journal-title":"Phys Ther"},{"issue":"8","key":"25_CR10","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","volume":"90","author":"BJ Petrof","year":"1993","unstructured":"Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90(8):3710\u20133714. https:\/\/doi.org\/10.1073\/pnas.90.8.3710","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"25_CR11","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1083\/jcb.122.4.809","volume":"122","author":"JM Ervasti","year":"1993","unstructured":"Ervasti JM, Campbell KP (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122(4):809\u2013823. https:\/\/doi.org\/10.1083\/jcb.122.4.809","journal-title":"J Cell Biol"},{"issue":"6","key":"25_CR12","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","volume":"66","author":"JM Ervasti","year":"1991","unstructured":"Ervasti JM, Campbell KP (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66(6):1121\u20131131. https:\/\/doi.org\/10.1016\/0092-8674(91)90035-W","journal-title":"Cell"},{"issue":"14","key":"25_CR13","doi-asserted-by":"publisher","first-page":"9161","DOI":"10.1016\/S0021-9258(18)31565-5","volume":"266","author":"JM Ervasti","year":"1991","unstructured":"Ervasti JM, Kahl SD, Campbell KP (1991) Purification of dystrophin from skeletal muscle. J Biol Chem 266(14):9161\u20139165. https:\/\/doi.org\/10.1016\/S0021-9258(18)31565-5","journal-title":"J Biol Chem"},{"issue":"6404","key":"25_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/360588a0","volume":"360","author":"K Matsumura","year":"1992","unstructured":"Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP (1992) Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360(6404):588\u2013591. https:\/\/doi.org\/10.1038\/360588a0","journal-title":"Nature"},{"issue":"6273","key":"25_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/345315a0","volume":"345","author":"JM Ervasti","year":"1990","unstructured":"Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345(6273):315\u2013319. https:\/\/doi.org\/10.1038\/345315a0","journal-title":"Nature"},{"issue":"6362","key":"25_CR16","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1038\/355696a0","volume":"355","author":"O Ibraghimov-Beskrovnaya","year":"1992","unstructured":"Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP (1992) Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355(6362):6696\u20136702. https:\/\/doi.org\/10.1038\/355696a0","journal-title":"Nature"},{"issue":"4","key":"25_CR17","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JND-170280","volume":"4","author":"Z Koeks","year":"2017","unstructured":"Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Bellgard MI, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Bari\u0161i\u0107 N, Brabec P, L\u00e4hdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Herczegfalvi A, Viswanathan V, Bayat F, Buccella F, Ferlini A, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Klein A, D\u00edaz-Manera J, Gallardo E, Karaduman AA, Oznur T, Topalo\u011flu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Kirschner J, Flanigan KM, Straub V, Bushby K, B\u00e9roud C, Verschuuren JJ, Lochm\u00fcller H (2017) Clinical outcomes in duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database. J Neuromuscul Dis 4(4):293\u2013306. https:\/\/doi.org\/10.3233\/JND-170280","journal-title":"J Neuromuscul Dis"},{"issue":"1","key":"25_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13023-017-0631-3","volume":"12","author":"S Ryder","year":"2017","unstructured":"Ryder S, Leadley RM, Armstrong N, Westwood M, de Kock S, Butt T, Jain M, Kleijnen J (2017) The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review. Orphanet J Rare Dis 12(1):79. https:\/\/doi.org\/10.1186\/s13023-017-0631-3","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"25_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0167-5273(90)90082-g","volume":"26","author":"G Nigro","year":"1990","unstructured":"Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271\u2013277. https:\/\/doi.org\/10.1016\/0167-5273(90)90082-g","journal-title":"Int J Cardiol"},{"issue":"16 Supplement","key":"25_CR20","doi-asserted-by":"crossref","first-page":"5.105","DOI":"10.1212\/WNL.88.16_supplement.P5.105","volume":"88","author":"F Schnell","year":"2017","unstructured":"Schnell F, Donoghue C, Dworzak J, Charleston J, Frank D, Wilton S (2017) Development of a validated Western blot method for quantification of human dystrophin protein used in Phase 700 II and III clinical trials of eteplirsen for the treatment of Duchenne muscular dystrophy (DMD). Neurology 88(16 Supplement):5.105","journal-title":"Neurology"},{"key":"25_CR21","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1177\/0883073810371004","volume":"9","author":"RT Moxley 3rd","year":"2010","unstructured":"Moxley RT 3rd, Pandya S, Ciafaloni E, Fox DJ, Campbell K (2010) Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 9:1116\u20131129. https:\/\/doi.org\/10.1177\/0883073810371004","journal-title":"J Child Neurol"},{"issue":"7","key":"25_CR22","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1083\/jcb.201110032","volume":"197","author":"JL Marshall","year":"2012","unstructured":"Marshall JL, Holmberg J, Chou E, Ocampo AC, Oh J, Lee J, Peter AK, Martin PT, Crosbie-Watson RH (2012) Sarcospan-dependent Akt activation is required for utrophin expression and muscle regeneration. J Cell Biol 197(7):1009\u20131027. https:\/\/doi.org\/10.1083\/jcb.201110032","journal-title":"J Cell Biol"},{"issue":"5","key":"25_CR23","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/hmg\/ddab276","volume":"31","author":"H Mamsa","year":"2022","unstructured":"Mamsa H, Stark RL, Shin KM, Beedle AM, Crosbie RH (2022) Sarcospan increases laminin-binding capacity of \u03b1-dystroglycan to ameliorate DMD independent of Galgt2. Hum Mol Genet. 31(5):718\u2013732. https:\/\/doi.org\/10.1093\/hmg\/ddab276","journal-title":"Hum Mol Genet."},{"issue":"3","key":"25_CR24","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1083\/jcb.200808027","volume":"183","author":"AK Peter","year":"2008","unstructured":"Peter AK, Marshall JL, Crosbie RH (2008) Sarcospan reduces dystrophic pathology: stabilization of the utrophin-glycoprotein complex. J Cell Biol 183(3):419\u2013427. https:\/\/doi.org\/10.1083\/jcb.200808027","journal-title":"J Cell Biol"},{"issue":"20","key":"25_CR25","doi-asserted-by":"publisher","first-page":"4378","DOI":"10.1093\/hmg\/dds271","volume":"21","author":"JL Marshall","year":"2012","unstructured":"Marshall JL, Chou E, Oh J, Kwok A, Burkin DJ, Crosbie-Watson RH (2012) Dystrophin and utrophin expression require sarcospan: loss of \u03b17 integrin exacerbates a newly discovered muscle phenotype in sarcospan-null mice. Hum Mol Genet 21(20):4378\u20134393. https:\/\/doi.org\/10.1093\/hmg\/dds271","journal-title":"Hum Mol Genet"},{"issue":"1","key":"25_CR26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13395-020-00244-3","volume":"10","author":"C Shu","year":"2020","unstructured":"Shu C, Parfenova L, Mokhonova E, Collado JR, Damoiseaux R, Campagna J, John V, Crosbie RH (2020) High-throughput screening identifies modulators of sarcospan that stabilize muscle cells and exhibit activity in the mouse model of Duchenne muscular dystrophy. Skelet Muscle 10(1):26. https:\/\/doi.org\/10.1186\/s13395-020-00244-3","journal-title":"Skelet Muscle"},{"issue":"1","key":"25_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13395-019-0218-x","volume":"9","author":"C Shu","year":"2019","unstructured":"Shu C, Kaxon-Rupp AN, Collado JR, Damoiseaux R, Crosbie RH (2019) Development of a high-throughput screen to identify small molecule enhancers of sarcospan for the treatment of Duchenne muscular dystrophy. Skelet Muscle 9(1):32. https:\/\/doi.org\/10.1186\/s13395-019-0218-x","journal-title":"Skelet Muscle"},{"issue":"7","key":"25_CR28","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1177\/1087057111405851","volume":"16","author":"XD Zhang","year":"2011","unstructured":"Zhang XD (2011) Illustration of SSMD, z score, SSMD*, z* score, and t statistic for hit selection in RNAi high-throughput screens. J Biomol Screen 16(7):775\u2013785. https:\/\/doi.org\/10.1177\/1087057111405851","journal-title":"J Biomol Screen"},{"issue":"2","key":"25_CR29","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1006\/dbio.1994.1103","volume":"162","author":"JE Morgan","year":"1994","unstructured":"Morgan JE, Beauchamp JR, Pagel CN, Peckham M, Ataliotis P, Jat PS, Noble MD, Farmer K, Partridge TA (1994) Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol 162(2):486\u2013498. https:\/\/doi.org\/10.1006\/dbio.1994.1103","journal-title":"Dev Biol"},{"issue":"1","key":"25_CR30","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/2044-5040-1-34","volume":"1","author":"K Mamchaoui","year":"2011","unstructured":"Mamchaoui K, Trollet C, Bigot A, Negroni E, Chaouch S, Wolff A, Kandalla PK, Marie S, Di Santo J, St Guily JL, Muntoni F, Kim J, Philippi S, Spuler S, Levy N, Blumen SC, Voit T, Wright WE, Aamiri A, Butler-Browne G, Mouly V (2011) Immortalized pathological human myoblasts: towards a universal tool for the study of neuromuscular disorders. Skelet Muscle 1(1):34. https:\/\/doi.org\/10.1186\/2044-5040-1-34","journal-title":"Skelet Muscle"}],"container-title":["Methods in Molecular Biology","Muscular Dystrophy Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2772-3_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T02:43:41Z","timestamp":1728441821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2772-3_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"ISBN":["9781071627716","9781071627723"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2772-3_25","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2022,11,19]]},"assertion":[{"value":"19 November 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}